Fair Value Measurements (Narrative) (Detail) (USD $) In Thousands, unless otherwise specified	12 Months Ended						12 Months Ended				1 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014 Rising Pharmaceuticals Inc.	Jun. 30, 2013 Rising Pharmaceuticals Inc.	Jun. 30, 2014 France Company	Apr. 30, 2014 PACK Pharmaceuticals, LLC	Jun. 30, 2014 Foreign exchange contract	Jun. 30, 2013 Foreign exchange contract	Jun. 30, 2012 Foreign exchange contract	Jun. 30, 2014 Interest rate swap	Apr. 30, 2014 Interest rate swap Cash flow hedging	Mar. 31, 2011 Interest rate swap Cash flow hedging	Jun. 30, 2014 Interest rate swap Cash flow hedging
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, notional amount							$ 42,755			$ 8,250	$ 25,750	$ 20,000	$ 26,750
Unrealized gains (losses) on hedging activities							(40)	(160)	(560)
Unrealized loss recorded in accumulated other comprehensive income	(437)	(258)
Derivative, interest rate											1.63%	1.91%
Derivative, expiration date											Apr. 30, 2019	Dec. 31, 2015
Contingent consideration at fair value			5,694	5,346	413	3,797
Contingent consideration, accrued interest expense	$ 438